Provision of the periodontal illness market to achieve market

Dublin, December 17th 2024 (Globe Newswire) – The “Market for periodontal disease with the type of disease (gingivitis, aggressive periodontitis, chronic periodontitis), type of treatment (flap surgery, root planning, bone transplantation), final user (Dental Hospitals) Reference has been added to Researchandmarkets.com offering.

The worldwide market for periodontal disease treatment is expected to reach $ 3.63 billion by US by 2030 from $ 2.58 billion in 2024, in a 5.9% CAGR during the forecast period. This is due to increased awareness of the relationship between oral health and overall systemic health, bringing the focus of both patients and health care provider to periodontal care.

Increased government campaigns to promote hygiene to the oral cavity and increased dental coverage insurance have also added a dynamic to this market. The increase in dental care infrastructure, especially in growing economies, further supplies this market. In addition, the adoption of minimally invasive procedures and biologists as well as the discovery of new drugs has increased the effectiveness of treatment, adding more fuels to the development of periodontal market factors during the prediction period of 2024-2030.

This report is studying the market for periodontal disease treatment equipment based on the type of disease, the type of treatment, the end user and the area. The report also studies factors (such as drivers, restrictions, opportunities and challenges) that affect market growth and provide details of the competitive landscape for market leaders. In addition, the report analyzes the small markets in relation to individual growth trends and provides the revenue of the market departments in relation to five major areas (and the respective countries in these areas).

The most important players operating in the market for periodontal disease treatment are Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), A-Dec Inc. (US), J. Morita Corp. (Japan), the Straumann Group (Switzerland), Biolase, Inc. (US), Bego Gmbh & Co. Kg (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., ltd. (Japan), Nakanishi Inc. (Japan), Dentalez, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), Newtom (Italy), Millennium Dental Technologies, Inc. ), Prexion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US) and Bien-Air Dental (US).

The chronic periodontitis sector of the periodontal disease treatment market to maintain the second longest prediction period

Based on the type of disease, the chronic periodontitis sector is expected to hold the second largest shares during the prediction period in the market for periodontal disease treatment equipment. This is due to the increasing number of older populations suffer from periodontal diseases. The situation will become more and more common, as chronic periodontitis is often found in elderly patients. Enhanced awareness of the relationship between oral health and systemic conditions, such as diabetes mellitus and cardiovascular disease, creates greater demand among patients to receive preventive and therapeutic care, which increases diagnoses and subsequent treatment .

The Renaissance Sector with guided tissue is the fastest growing sector in the periodontal disease treatment market

Based on the type of treatment, the market for periodontal disease treatment is divided into non -surgical treatment, flap surgery, soft tissue cuttings, bone cuttings, regeneration with tissues and other treatments. The Renaissance Sector with guided tissue is expected to grow at the highest CAGR due to its central role in research and the development of periodontal disease (R&D). Organic materials and tissue mechanics have been made, leading to newer and more efficient and biocompatible membranes with better results. GTR processes are increasingly adopted by dental professionals and increasing training and availability of specialized equipment have made it very dynamic. Favorable compensation policies in various areas, coupled with the upgrading of cosmetic dentistry, also played an important role in the high growth rate of the GTR market.

Europe represented the second largest share of the periodontal disease treatment market per region

The global market for periodontal diseases treatment is divided into five large regions, namely North America, Europe, Asia -Pacific, Latin America and the Middle East and Africa. Europe is the second largest regional market for periodontal disease treatment equipment, while the Asia -Pacific market is estimated to grow at the highest CAGR during the prediction period.

Europe holds the second largest position in the market for periodontal treatment equipment. The area has a well -established health infrastructure that provides better access to advanced dental care. In addition, the significant increase in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in Europe. The high awareness of the oral health and preventive care services available in European countries further promote the expansion of this market. Favorable government policies and return refund frames for dental care therapies, along with a high -end dental insurance coverage among patients, argue them to receive periodontal treatments. Continuing research and development in dental technologies and biomaterials, including countries such as Germany and Switzerland, also support this expansion in the area.

Basic features

Market dynamics

• Guides
  • Increase the prevalence of oral disorders
  • Increase Edentulism Case
  • Display innovative dental treatment procedures
  • Extension of dental tourism market to emerging economies
• Restrictions
  • High cost of advanced treatments and inadequate returns for dental procedures
• Opportunities
  • Impact of DSOS on dental industry
  • Increasing awareness of oral health
• Challenges
  • Lack of specialized dentists

Case Study Analysis

• Case Study 1: Innovation monitoring, technology evaluation and product launches in antimicrobial agents and coating substances for dental implants
• Case Study 2: Custom study for MEA
• Case Study 3: Customized study on Latin America

Additional topics analyzed in the report

• Industry
• Technology analysis
• Chain analysis
• Ecosystem map
• Supply chain analysis
• Regulatory analysis
• Analysis of patents
• Analytical analysis
• Trends/disorders that affect customer businesses
• Neighboring purchases to treat periodontal disease
• Basic Conferences and Events, 2024
• Pricing analysis
• Basically interested parties and market criteria
• Independent Needs in Market for Periodontal Disease Therapy
• Investment and Funding scenario
• Prevalence of gum cases in basic countries
• Analysis of the total number of surgery in basic countries

The companies presented in this report on periodontal treatment of the disease

• Dentsply sirona
• Envista Holdings Corporation
• Institut Straumann AG
• Henry Schein, Inc.
• Biolase, Inc.
• Geistlich Pharma AG
• J. Morita Corp.
• Nakanishi Inc.
• A-Dec Inc.
• RTI surgery
• Yoshida Dental MFG. CO. Ltd.
• Keystone Dental Inc.
• Ultradent Products, Inc.
• BEGO GMBH & CO. Kg
• Dentalez Inc.
• Parkell, Inc.
• Millennium Dental Technologies Inc.
• Brasseler USA
• AMD Lasers
• Nova Instruments
• Botiss biomaterials gmbh
• Dental
• Neurovolous
• Courtesy
• Hannox International Corp.

For more information on this report visit

For Researchandmarkets.com
Researchandmarkets.com is the world’s leading source for international market research fairs and market data. We provide you with the latest data on international and regional markets, basic industries, leading companies, new products and the latest trends.

• Purchase of Periodontal Disease Therapy